4DMedical is trading at A$3.08, down 6.10%, with no verified catalyst identified for the October 30 decline.
- The October 28 quarterly report showed revenue up 66% and record scan volumes.
- The AGM produced a first strike on the remuneration report, but neither source establishes a cause for the decline.
- Shares had also fallen in recent sessions; available evidence does not confirm a specific catalyst for today’s decline.